Traditional peptide therapy has frequently been hindered by suboptimal bioavailability and chemical stability. However, cutting-edge approaches are fueling a genuine shift in peptide engineering. Such next-generation peptides, featuring non-standard amino acids, cyclic structures, and advanced l